Approval · Notice of Compliance 10978 · 2010
DILANTIN: Notice of Compliance 10978
Issued January 28, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10978
- Date
- January 28, 2010
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in manufacturing site and changes in formulation
- Therapeutic class
- Anticonvulsant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DILANTIN | Not yet assigned | — |
Medicinal ingredients
- PHENYTOIN SODIUM 30 MG per CAP